Pacira | PCRX - Gewinn Vor Steuern





Gewinn Vor Steuern Veränderung Datum
Assertio Holdings USD -2.88M 648K 2024-09
Astellas Pharma JPY 48.02B 85.93B 2026-03
Bristol-Myers Squibb USD 1.47B 1.64B 2025-12
Cara Therapeutics USD -4.91M 3.17M 2025-03
Coherus Biosciences USD -46.35M 90.86M 2025-12
Heron Therapeutics USD -2.95M 14.54M 2025-12
Ironwood Pharmaceuticals USD 68.02M 30.2M 2025-09
J&J USD 7.82B 2.86B 2026-03
Ligand Pharmaceuticals USD 56.78M 84.36M 2025-12
Nektar Therapeutics USD -34.7M 2.35M 2025-12
Novo Nordisk DKK 33.8B 3.23B 2025-06
Omeros USD -65.12M 21.27M 2024-06
Pacira USD 571K 8.95M 2025-12
Perrigo USD -1.33B 1.35B 2025-12
Pfizer USD 5.18B 6.82B 2026-03
Supernus Pharmaceuticals USD -5.95M 4.04M 2026-03
Teva Pharmaceutical Industries USD 753M 662M 2026-03
Xeris Pharmaceuticals USD 11.08M 10.46M 2025-12
Xoma USD 15.98M 24.58M 2024-06
Zoetis USD 761M 126M 2025-12